![](/img/cover-not-exists.png)
Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models
Kenmogne, Lucie Carolle, Roy, Jenny, Maltais, René, Rouleau, Mélanie, Neveu, Bertrand, Pouliot, Frédéric, Poirier, Donald, Culig, ZoranVolume:
12
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0171871
Date:
February, 2017
File:
PDF, 3.98 MB
english, 2017